Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
7
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
7
×
seattle top stories
startups
takeda pharmaceutical
7
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
eli lilly
fda
cancer immunotherapy
clinical trials
investing
ipo
novartis
pfizer
alzheimer's disease
What
bio
roundup
7
×
drugs
pharmaceutical
acquisitions
buy
ceo
daniel
drug
gilead
o’day
sciences
typically
ahead
alliance
alzheimer’s
announced
appetite
asco
bails
biggest
black
brand
branded
bread
bridgebio
bristol
build
butter
buyout
calls
cancer
capital
car
cash
changing
choices
collabs
color
commissioner
Language
unset
Current search:
roundup
×
" takeda pharmaceutical "
×
" seattle blog main "
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More